Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
JPMorgan lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $45 from $47 and keeps a Neutral rating on the shares. The firm ...
Metagenomi (NASDAQ:MGX) vs. Kodiak Sciences (NASDAQ:KOD) Financial Survey
Metagenomi (NASDAQ:MGX – Get Free Report) and Kodiak Sciences (NASDAQ:KOD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies ...
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...